» Articles » PMID: 20223231

MicroRNA-21 (miR-21) Represses Tumor Suppressor PTEN and Promotes Growth and Invasion in Non-small Cell Lung Cancer (NSCLC)

Overview
Journal Clin Chim Acta
Specialty Biochemistry
Date 2010 Mar 13
PMID 20223231
Citations 279
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MicroRNAs (miRNAs) are a class of small non-coding RNAs regulating gene expression that play roles in the pathogenesis of human diseases, including malignancy. miR-21, a commonly overexpressed miRNA in very diverse types of malignancies, may affect tumor progression through targeting tumor suppressor genes. We identified the role of miR-21 in non-small cell lung cancer (NSCLC) and to clarify the regulation of PTEN by miR-21 and determine mechanisms of this regulation.

Methods: Expression of miR-21 and PTEN in 20 paired NSCLC and adjacent non-tumor lung tissues was investigated by qRT-PCR and western blot, respectively. The effect of miR-21 on PTEN expression was assessed in NSCLC cell lines with miR-21 inhibitor to decrease miR-21 expression. Furthermore, the roles of miR-21 in cell growth and invasion were analyzed with miR-21 inhibitor-transfected cells.

Results: miR-21 was overexpressed in tumor tissues relative to adjacent non-tumor tissues. Notably, patients with advanced clinical TNM stage (n=16) or distal metastasis (n=5) demonstrated higher miR-21 expression than those without them (n=26, or n=37) (p<0.05, or p<0.001). Tumor tissues showed an inverse correlation between miR-21 and PTEN protein. miR-21 inhibitor transfection increased a luciferase-reporter activity containing the PTEN-3'-UTR construct and increased PTEN protein but not PTEN-mRNA levels in NSCLC cell lines. Finally, miR-21 inhibitor-transfected cells exhibited markedly reduced cell growth and invasive characteristics.

Conclusions: miR-21 post-transcriptionally down-regulates the expression of tumor suppressor PTEN and stimulates growth and invasion in NSCLC. It may be a potential therapeutic target for NSCLC.

Citing Articles

MicroRNA155 in non-small cell lung cancer: a potential therapeutic target.

Wei X, Xiong X, Chen Z, Chen B, Zhang C, Zhang W Front Oncol. 2025; 15:1517995.

PMID: 39963112 PMC: 11830606. DOI: 10.3389/fonc.2025.1517995.


Nucleic acid therapeutics: Past, present, and future.

Naeem S, Zhang J, Zhang Y, Wang Y Mol Ther Nucleic Acids. 2025; 36(1):102440.

PMID: 39897578 PMC: 11786870. DOI: 10.1016/j.omtn.2024.102440.


RNA Metabolism and the Role of Small RNAs in Regulating Multiple Aspects of RNA Metabolism.

Dawar P, Adhikari I, Mandal S, Jayee B Noncoding RNA. 2025; 11(1.

PMID: 39846679 PMC: 11755482. DOI: 10.3390/ncrna11010001.


Plasma microRNAs as Biomarkers for Predicting Radiotherapy Treatment-Induced Cardiotoxicity in Lung Cancer.

Kazlauskaite P, Vaicekauskaite I, Venius J, Sabaliauskaite R, Steponaviciene R Life (Basel). 2025; 14(12.

PMID: 39768327 PMC: 11679788. DOI: 10.3390/life14121619.


The Ambivalent Role of miRNA-21 in Trauma and Acute Organ Injury.

Ritter A, Han J, Bianconi S, Henrich D, Marzi I, Leppik L Int J Mol Sci. 2024; 25(20).

PMID: 39457065 PMC: 11508407. DOI: 10.3390/ijms252011282.